$0.749
-0.089 (-11.91%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CHRS por análisis de gráficos similares
Alphio's CHRS stock price prediction model matches the current Coherus Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.75 (+0.03%). The 1-week path is $0.76 (+1.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Coherus Oncology Inc?
Coherus BioSciences Inc (CHRS) appears to be a good buy at the current price of $0.7494, especially considering its RSI of 23.693, indicating it is oversold. The company has a strong gross margin of 70.35% in Q2 2026, which suggests efficient cost management and potential for profitability as revenues grow. However, the main risk is the forward P/E of 41.1523, indicating high expectations for future earnings that may not materialize, especially given the recent net income losses.
CHRS cerró en $0.75 el Thursday, tras bajar -11.91%
Coherus Oncology Inc (CHRS) last closed at $0.7489, losing -11.91%. These facts feed the 1-day and 1-week CHRS price prediction above.
Consenso de analistas
Coherus Oncology Inc (CHRS): 8 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Coherus Oncology Inc (CHRS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CHRS, ordenadas por similitud.
Análisis de estacionalidad de CHRS
Historically the probability of a positive November return for CHRS is 9.30%. January offers the highest probability of a positive month at 44.26%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CHRS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.63 | $0.65 | $0.72 | -13.86% |
| Dec 2026 | $0.58 | $0.70 | $0.75 | -6.25% |
En 2026, se proyecta que Coherus Oncology Inc (CHRS) oscile entre $0.58 y $0.75.
Previsión mensual de Coherus Oncology Inc para 2026
En Nov de 2026, se proyecta que Coherus Oncology Inc promedie $0.65, con un mínimo de $0.63 y un máximo de $0.72.
En Dec de 2026, se proyecta que Coherus Oncology Inc promedie $0.70, con un mínimo de $0.58 y un máximo de $0.75.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.